Aminologics Co Ltd
KOSDAQ:074430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aminologics Co Ltd
Total Current Liabilities
Aminologics Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aminologics Co Ltd
KOSDAQ:074430
|
Total Current Liabilities
₩27.6B
|
CAGR 3-Years
100%
|
CAGR 5-Years
35%
|
CAGR 10-Years
17%
|
|
|
SK IE Technology Co Ltd
KRX:361610
|
Total Current Liabilities
₩657.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Hansol Chemical Co Ltd
KRX:014680
|
Total Current Liabilities
₩274.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
Total Current Liabilities
₩579.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
S
|
SoulBrain Co Ltd
KOSDAQ:357780
|
Total Current Liabilities
₩123.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
Total Current Liabilities
₩164.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aminologics Co Ltd
Glance View
Aminologics Co., Ltd. engages in the manufacture and sale of amino acids and amino acid derivatives. The company is headquartered in Seoul, Seoul. The company went IPO on 2004-06-04. is a Korea-based company mainly engaged in the manufacture and distribution of image processing chips for digital video recorders (DVRs). The firm operates its business through in two divisions: information technology (IT) division and amino acid division. Its IT division engages in the manufacture of DVR system-on-chips (SoCs), analog and digital integrated chips, multiplexer and display chips, color quad chips, video codec, peripheral component interconnect (PCI) one chips and others. Its amino acid division produces unnatural amino acids, which are used for pharmaceutical development. On July 29, 2013, the Company sold its entire shares of U-CHANG PLANT CONSTRUCTION CO., LTD. On December 23, 2013, Sam-Oh Pharm Co Ltd became the largest shareholder of the Company by acquiring a 16.67% stake in the Company.
See Also
What is Aminologics Co Ltd's Total Current Liabilities?
Total Current Liabilities
27.6B
KRW
Based on the financial report for Dec 31, 2025, Aminologics Co Ltd's Total Current Liabilities amounts to 27.6B KRW.
What is Aminologics Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
17%
Over the last year, the Total Current Liabilities growth was 535%. The average annual Total Current Liabilities growth rates for Aminologics Co Ltd have been 100% over the past three years , 35% over the past five years , and 17% over the past ten years .
